Insmed to Host Second-Quarter 2025 Financial Results Conference Call on Thursday, August 7, 2025

Rhea-AI Summary

Insmed (Nasdaq: INSM) has scheduled its second-quarter 2025 financial results conference call for Thursday, August 7, 2025, at 8:00 a.m. ET. The company will release its financial results the same day.

Investors can join the conference call by dialing (888) 210-2654 (U.S.) or (646) 960-0278 (international) using access code 7862189. A live webcast will be available on Insmed's website. The call replay will be accessible until August 14, 2025, and the webcast recording will be archived for 90 days on the company's investor relations website.

BRIDGEWATER, N.J., July 24, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its second-quarter 2025 financial results on Thursday, August 7, 2025.

Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, August 7, 2025, to discuss financial results and provide a business update.

Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) and referencing access code 7862189. The call will also be webcast live on the Company's website at www.insmed.com.

A replay of the conference call will be accessible approximately 1 hour after its completion through August 14, 2025, by dialing (800) 770-2030 (U.S.) and (609) 800-9909 (international) and referencing access code 7862189. A webcast of the call will also be archived for 90 days under the Investor Relations section of the Company's website at www.insmed.com.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending four consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more.

Contact:

Investors:

Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com

Media:

Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-second-quarter-2025-financial-results-conference-call-on-thursday-august-7-2025-302510009.html

SOURCE Insmed Incorporated

FAQ

When will Insmed (INSM) report Q2 2025 earnings?

Insmed will release its Q2 2025 financial results on Thursday, August 7, 2025, followed by a conference call at 8:00 a.m. ET.

How can investors access Insmed's Q2 2025 earnings call?

Investors can dial (888) 210-2654 (U.S.) or (646) 960-0278 (international) with access code 7862189, or watch the live webcast on www.insmed.com.

How long will Insmed's Q2 2025 earnings call replay be available?

The call replay will be available until August 14, 2025, and the webcast recording will be archived for 90 days on Insmed's investor relations website.

What is the access code for Insmed's Q2 2025 earnings call?

The access code for both the live call and replay is 7862189.